Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer.

CONTEXT Although partial nephrectomy is the preferred treatment for many patients with early-stage kidney cancer, recent clinical trial data, which demonstrate better survival for patients treated with radical nephrectomy, have generated new uncertainty regarding the comparative effectiveness of these treatment options. OBJECTIVE To compare long-term survival after partial vs radical nephrectomy among a population-based patient cohort whose treatment reflects contemporary surgical practice. DESIGN, SETTING, AND PATIENTS We performed a retrospective cohort study of Medicare beneficiaries with clinical stage T1a kidney cancer treated with partial or radical nephrectomy from 1992 through 2007. Using an instrumental variable approach to account for measured and unmeasured differences between treatment groups, we fit a 2-stage residual inclusion model to estimate the treatment effect of partial nephrectomy on long-term survival. MAIN OUTCOME MEASURES Overall and kidney cancer-specific survival. RESULTS Among 7138 Medicare beneficiaries with early-stage kidney cancer, we identified 1925 patients (27.0%) treated with partial nephrectomy and 5213 patients (73.0%) treated with radical nephrectomy. During a median follow-up of 62 months, 487 (25.3%) and 2164 (41.5%) patients died following partial or radical nephrectomy, respectively. Kidney cancer was the cause of death for 37 patients (1.9%) treated with partial nephrectomy, and 222 patients (4.3%) treated with radical nephrectomy. Patients treated with partial nephrectomy had a significantly lower risk of death (hazard ratio [HR], 0.54; 95% CI, 0.34-0.85). This corresponded with a predicted survival increase with partial nephrectomy of 5.6 (95% CI, 1.9-9.3), 11.8 (95% CI, 3.9-19.7), and 15.5 (95% CI, 5.0-26.0) percentage points at 2, 5, and 8 years posttreatment (P < .001). No difference was noted in kidney cancer-specific survival (HR, 0.82; 95% CI, 0.19-3.49). CONCLUSION Among Medicare beneficiaries with early-stage kidney cancer who were candidates for either surgery, treatment with partial rather than radical nephrectomy was associated with improved survival.

[1]  B. Hankey,et al.  The surveillance, epidemiology, and end results program: a national resource. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[2]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[3]  Deborah Schrag,et al.  Overview of the SEER-Medicare Data: Content, Research Applications, and Generalizability to the United States Elderly Population , 2002, Medical care.

[4]  A. D'Amico,et al.  Comorbidity and mortality results from a randomized prostate cancer screening trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  E. Guadagnoli,et al.  Patient Demographic and Socioeconomic Characteristics in the SEER-Medicare Database: Applications and Limitations , 2002, Medical care.

[6]  Stephanie Daignault,et al.  Rising incidence of small renal masses: a need to reassess treatment effect. , 2007, Journal of the National Cancer Institute.

[7]  J L Warren,et al.  Rising incidence of renal cell cancer in the United States. , 1999, JAMA.

[8]  A. Novick.  The role of renal-sparing surgery for renal cell carcinoma. , 1992, Seminars in urology.

[9]  David C. Miller,et al.  External validation of a claims-based algorithm for classifying kidney-cancer surgeries , 2009, BMC health services research.

[10]  J. Newhouse,et al.  Econometrics in outcomes research: the use of instrumental variables. , 1998, Annual review of public health.

[11]  Louis R Kavoussi,et al.  Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. , 2007, The Journal of urology.

[12]  Andrew J Vickers,et al.  Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. , 2006, The Lancet. Oncology.

[13]  L I Iezzoni,et al.  Use of administrative data to find substandard care: validation of the complications screening program. , 2000, Medical care.

[14]  M. Schonlau,et al.  Disparities in the treatment of patients with IL-2 for metastatic renal cell carcinoma. , 2010, Urologic oncology.

[15]  R. Sylvester,et al.  A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. , 2011, European urology.

[16]  David C. Miller,et al.  Contemporary clinical epidemiology of renal cell carcinoma: insight from a population based case-control study. , 2010, The Journal of urology.

[17]  B. Hollenbeck,et al.  Five‐year survival after surgical treatment for kidney cancer , 2007, Cancer.

[18]  Elliott S Fisher,et al.  Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. , 2007, JAMA.

[19]  L I Iezzoni,et al.  Identifying Complications of Care Using Administrative Data , 1994, Medical care.

[20]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[21]  K. Harris,et al.  Who is the marginal patient? Understanding instrumental variables estimates of treatment effects. , 1998, Health services research.

[22]  Robert G Uzzo,et al.  Comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys reveals predominant role of nonmodifiable factors in determining ultimate renal function. , 2011, The Journal of urology.

[23]  John T. Wei,et al.  Complications and failure to rescue after laparoscopic versus open radical nephrectomy. , 2011, The Journal of urology.

[24]  W. Lowrance,et al.  Trends in renal tumor surgery delivery within the United States , 2010, Cancer.

[25]  Inderbir S Gill,et al.  Every minute counts when the renal hilum is clamped during partial nephrectomy. , 2010, European urology.

[26]  A. Weaver,et al.  Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. , 2000, Mayo Clinic proceedings.

[27]  T. Jang,et al.  Survival rates after resection for localized kidney cancer: 1989 to 2004 , 2008, Cancer.

[28]  Novick Ac.  The role of renal-sparing surgery for renal cell carcinoma. , 1992 .

[29]  R. Sylvester,et al.  A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. , 2007, European urology.

[30]  A. Miller.  New data on prostate-cancer mortality after PSA screening. , 2012, The New England journal of medicine.

[31]  Richard L. Morrill,et al.  METROPOLITAN, URBAN, AND RURAL COMMUTING AREAS: TOWARD A BETTER DEPICTION OF THE UNITED STATES SETTLEMENT SYSTEM , 1999 .

[32]  J. Terza,et al.  The use of linear instrumental variables methods in health services research and health economics: a cautionary note. , 2007, Health services research.

[33]  Paul Russo,et al.  Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes? , 2009, The Journal of urology.

[34]  T. Jang,et al.  Survival rates after resection for localized kidney cancer: 1989 - 2004 , 2008 .

[35]  E. Steyerberg,et al.  The effect of study arm on prostate cancer treatment in the large screening trial ERSPC , 2010, International journal of cancer.

[36]  A. Novick,et al.  Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. , 2000, The Journal of urology.

[37]  S. Matin,et al.  Guideline for management of the clinical stage 1 renal mass , 2009 .

[38]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[39]  M. Cooperberg,et al.  Treatment trends for stage I renal cell carcinoma. , 2011, The Journal of urology.

[40]  J. Kaouk,et al.  Guideline for management of the clinical T1 renal mass. , 2009, The Journal of urology.

[41]  David C. Miller,et al.  Partial nephrectomy for small renal masses: an emerging quality of care concern? , 2006, The Journal of urology.

[42]  Paul J Rathouz,et al.  Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling. , 2008, Journal of health economics.

[43]  John T. Wei,et al.  National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization? , 2006, Urology.

[44]  Stephen A Boorjian,et al.  Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. , 2008, The Journal of urology.

[45]  H. Fukuda,et al.  European Organization for Research and Treatment of Cancer (EORTC) and International Society for Cutaneous Lymphoma (ISCL) consensus recommendations for the management of cutaneous B-cell lymphomas Blood 2008; 112(5):1600-9 , 2022 .

[46]  M. Schonlau,et al.  Renal and cardiovascular morbidity after partial or radical nephrectomy , 2008, Cancer.

[47]  F. Saad,et al.  Radical versus partial nephrectomy , 2009, Cancer.

[48]  A. Vickers,et al.  Do the data support the comorbidity hypothesis for the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial results? , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  J. Stock,et al.  Instrumental Variables Regression with Weak Instruments , 1994 .